POST-COVID 19

Clinical trials for POST-COVID 19 explained in plain language.

Never miss a new study

Get alerted when new POST-COVID 19 trials appear

Sign up with your email to follow new studies for POST-COVID 19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could a common antidepressant ease the debilitating fatigue of long COVID?

Symptom relief Not yet recruiting

This study aims to see if fluvoxamine, a medication often used for depression and anxiety, can help reduce severe fatigue, brain fog, and other common symptoms in people with Long COVID. Researchers will give 160 participants either fluvoxamine or a placebo pill for 12 weeks to c…

Matched conditions: POST-COVID 19

Phase: PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief

Last updated Apr 02, 2026 05:26 UTC

POST-COVID 19

Get alerted when new POST-COVID 19 trials appear

Could a common antidepressant ease the debilitating fatigue of long COVID?